TOPOLOGY OF SPHINGOLIPID GALACTOSYLTRANSFERASES IN ER AND GOLGI - TRANSBILAYER MOVEMENT OF MONOHEXOSYL SPHINGOLIPIDS IS REQUIRED FOR HIGHERGLYCOSPHINGOLIPID BIOSYNTHESIS
Knj. Burger et al., TOPOLOGY OF SPHINGOLIPID GALACTOSYLTRANSFERASES IN ER AND GOLGI - TRANSBILAYER MOVEMENT OF MONOHEXOSYL SPHINGOLIPIDS IS REQUIRED FOR HIGHERGLYCOSPHINGOLIPID BIOSYNTHESIS, The Journal of cell biology, 133(1), 1996, pp. 15-28
Glucosylceramide (GlcCer) is synthesized at the cytosolic surface of t
he Golgi complex while enzymes acting in late steps of glycosphingolip
id biosynthesis have their active centers in the Golgi lumen. However,
the topology of the ''early'' galactose-transferring enzymes is large
ly unknown. We used short-chain ceramides with either a 2-hydroxy fatt
y acid (HFA) or a normal fatty acid (NFA) to determine the topology of
the galactosyltransferases involved in the formation of HFA- and NFA-
galactosylceramide (Gal-Cer), lactosylceramide (LacCer), and galabiosy
lceramide (Ga(2)Cer). Although the HFA-GalCer synthesizing activity co
localized with an ER marker, the other enzyme activities fractionated
at the Golgi density of a sucrose gradient. In cell homogenates and pe
rmeabilized cells, newly synthesized short-chain GlcCer and GalCer wer
e accessible to serum albumin, whereas LacCer and Ga(2)Cer were protec
ted. From this and from the results obtained after protease treatment,
and after interfering with UDP-Gal import into the Golgi, we conclude
that (a) GlcCer and NFA-GalCer are synthesized in the cytosolic leafl
et, while LacCer and Ga(2)Cer are synthesized in the lumenal leaflet o
f the Golgi. (b) HFA-Gal-Cer is synthesized in the lumenal leaflet of
the ER, but has rapid access to the cytosolic leaflet, (c) GlcCer, NFA
-GalCer, and HFA-GalCer translocate from the cytosolic to the lumenal
leaflet of the Golgi membrane. The transbilayer movement of GlcCer and
NFA-GalCer in the Golgi complex is an absolute requirement for higher
glycosphingolipid biosynthesis and for the cell surface expression of
these monohexosyl sphingolipids.